Novo Nordisk
Page 8 of 9
RetailSo many Americans are using Novo Nordisk’s blockbuster weight loss-aiding Ozempic that Germany may ban exports of the drug
By Ryan HoggNovember 16, 2023

RetailScientists have discovered a new benefit to Novo Nordisk’s weight-loss drug Wegovy: It can cut heart-related deaths by 20%, drugmaker reports
By Prarthana PrakashNovember 13, 2023

HealthA ‘game-changing’ study backs Wegovy use to cut heart attacks and strokes: ‘This is not just about weight and appearance’
By Madison Muller, Naomi Kresge and BloombergNovember 11, 2023

By Ryan HoggNovember 6, 2023

HealthNovo Nordisk isn’t alone: Sales of Ozempic rival Mounjaro explode as drugmaker Eli Lilly profits from Americans’ weight-loss craze
By Prarthana PrakashNovember 3, 2023

HealthBrands like Walmart and Nestle are right to worry about Wegovy. Novo Nordisk sold $900m of the weight loss drug last quarter—and 95% was in the U.S.
By Ryan HoggNovember 2, 2023

CompaniesPepsi’s CEO is keeping an eye on weight-loss drugs, but shakes off fears voiced by Walmart that they could hurt the bottom line
By Christiaan HetznerOctober 11, 2023

FinanceWall Street is now betting against restaurant stocks because of Novo Nordisk’s Ozempic and high interest rates
By Prarthana PrakashOctober 10, 2023

LifestyleWeight-loss-aiding drugs Ozempic and Wegovy are dampening food sales, top Walmart exec says
By Chloe TaylorOctober 5, 2023

FinanceDrugs aiding weight-loss like Ozempic have so much promise, a major bank is telling investors to short junk-food credit
By Prarthana PrakashOctober 4, 2023

EuropeThe theory that luxury stocks are Europe’s strongest response to Wall Street’s high-flying tech stocks is being put to the test
By Julien Ponthus, Michael Msika and BloombergSeptember 10, 2023

MagazineInsulin’s deadly cost: Ultrahigh prices in the U.S. mean many diabetics can’t afford the medication they need to survive
By Geoff ColvinDecember 6, 2021

TechNew venture fund backs CytoSeek, a startup looking to give “superpowers” to cancer-fighting T-cells
By Jeremy KahnMarch 16, 2021

By Sy MukherjeeDecember 6, 2016
Most Popular



